CorEvitas, LLC, the gold-standard provider of real-world evidence solutions for the life sciences industry, announced that it has received the 2023 BOBI (Best of Business Intelligence) Award for Best Use of Innovation from the British Healthcare Business Intelligence Association (BHBIA) at their annual awards gala on June 12, 2023. The BOBI Awards recognize excellence across the healthcare business intelligence spectrum.
CorEvitas was recognized for its innovative Vantage Simulations solution, a patient pathway mapping and modeling tool. This award recognized the irritable bowel disease (IBD) pathway simulation model developed by CorEvitas and Biogen to support infusion clinics struggling with a high patient load, by identifying the resources and equipment required for a robust, sustainable infusion service. Creating transparency around the patient pathway, then adding real-world data and configurable local inputs, facilitates informed and evidence-driven planning by clinicians and commissioners to optimize services and improve patient outcomes.
Also Read: SimonMed Imaging Implements 3rd Generation iCAD Breast AI 3.0
“COVID-19 brought shortcomings and inequalities within the National Health System (NHS) sharply into focus, while the introduction of Integrated Care Systems (ICSs) requires clinical pathways to be restructured to realize targets and service efficiencies,” emphasized Parita Patel, CorEvitas Product Director. “The need for digital tools to support decision-making is pressing, and our user-friendly, real-world data-driven modeling tool transforms the approach to service redesign, enabling confident and quick decision-making by healthcare providers and practitioners.”
IBD has a profound impact on a patient’s life, requiring lifelong expert care and treatment. One in every 123 people living in the UK suffers from Crohn’s disease or colitis, increasing to one in every 67 people over 70.5 years of age. There is currently no cure for either disease, and the financial impact on the NHS for IBD care is comparable to conditions like heart disease and cancer. The 15 million people in England with long-term conditions like IBD have the greatest healthcare needs of the population.
Biogen and CorEvitas are delighted to be recognized by the BHBIA and BOBI Awards for their innovative IBD pathway simulation model. The BOBI Awards team commented, “The judges were impressed with the wide-reaching impact, including positive impact on the NHS…the approach was really innovative.”
SOURCE: PRNewswire